Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ubiquitin specific peptidase 17 like family member 25 (USP17L25) is a member of the ubiquitin-specific protease (USP) family of cysteine proteases that specifically removes ubiquitin from conjugated proteins. This enzyme plays a critical role in regulating the stability, localization, and activity of numerous proteins involved in cell proliferation, apoptosis, and cell migration. It has RNA binding and hyaluronic acid binding activity, localizes mainly to the nucleolus, and influences epithelial cell apoptosis and other ubiquitin-dependent proteolytic processes. USP17L25 and its broader gene family have been implicated as potential targets in cancer biology, especially in the regulation of epithelial-mesenchymal transition and in neurodegenerative conditions such as Machado-Joseph disease.
Removal of conjugated ubiquitin from substrate proteins, thereby regulating protein degradation, signaling, and function
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ubiquitin specific peptidase 17 like family member 25 (USP17L25).